Corporate insider profile
Charles W. Newton Insider Trades
Latest reported as Director of Keros Therapeutics, Inc. (KROS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$11,197.30
- Latest transaction
- Aug 18, 2026
Affiliated corporations
Reported company relationships
Transaction history
